Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Ambey Laboratories IPO is a book build issue of ₹44.68 crores. The issue is a combination of fresh issue of 0.63 crore shares aggregating to ₹42.55 crores and offer for sale of 0.03 crore shares aggregating to ₹2.12 crores.
Ambey Laboratories IPO bidding started from Jul 4, 2024 and ended on Jul 8, 2024. The allotment for Ambey Laboratories IPO was finalized on Jul 9, 2024. The shares got listed on NSE SME on Jul 11, 2024.
Ambey Laboratories IPO price band is set at ₹68.00 per share . The lot size for an application is 2,000. The minimum amount of investment required by an retail is ₹1,30,000 (2000 shares). The minimum lot size investment for HNI is 2 lots (4,000 shares), amounting to ₹2,72,000.
Fast Track Finsec Pvt.Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue. The market maker of the company is Nikunj Stock Brokers Ltd..
Refer to Ambey Laboratories IPO RHP for detailed Information.
| IPO Date | July 4, 2024 to July 8, 2024 |
| Listing Date | July 11, 2024 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹65 to ₹68 per share |
| Issue Price Final | ₹68 per share |
| Lot Size | 2,000 Shares |
| Sale Type | Fresh Capital-cum-Offer for Sale |
| Total Issue Size | 65,70,000 shares (aggregating up to ₹44.68 Cr) |
| Reserved for Market Maker | 3,30,000 shares Nikunj Stock Brokers Ltd. (aggregating up to ₹2.24 Cr) |
| Fresh Issue (Ex Market Maker) | 59,28,000 shares (aggregating up to ₹40.31 Cr) |
| Offer for Sale | 3,12,000 shares of ₹10 (aggregating up to ₹2.12 Cr) |
| Net Offered to Public | 62,40,000 shares (aggregating up to ₹42.43 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,86,88,819 shares |
| Share Holding Post Issue | 2,52,58,819 shares |
Ambey Laboratories IPO offers total 65,70,000 shares. Out of which 31,20,000 (47.49%) allocated to QIB, 12,48,000 (19.00%) allocated to QIB, 9,36,000 (14.25%) allocated to NII, 21,84,000 (33.24%) allocated to RII and 18,72,000 (28.49%) allocated to Anchor investors.
| Investor Category | Shares Offered |
|---|---|
| Market Maker Shares Offered | 3,30,000 (5.02%) |
| QIB Shares Offered | 31,20,000 (47.49%) |
| − Anchor Investor Shares Offered | 18,72,000 (28.49%) |
| − QIB (Ex. Anchor) Shares Offered | 12,48,000 (19.00%) |
| NII (HNI) Shares Offered | 9,36,000 (14.25%) |
| Retail Shares Offered | 21,84,000 (33.24%) |
| Total Shares Offered | 65,70,000 (100.00%) |
Ambey Laboratories IPO raises ₹12.73 crore from anchor investors. Ambey Laboratories IPO Anchor bid date is July 3, 2024. Ambey Laboratories IPO Anchor Investors list
| Bid Date | July 3, 2024 |
| Shares Offered | 18,72,000 |
| Anchor Portion Size (In Cr.) | 12.73 |
| Anchor lock-in period end date for 50% shares (30 Days) | August 8, 2024 |
| Anchor lock-in period end date for remaining shares (90 Days) | October 7, 2024 |
Ambey Laboratories IPO opens on July 4, 2024, and closes on July 8, 2024.
| IPO Open Date | Thu, Jul 4, 2024 |
| IPO Close Date | Mon, Jul 8, 2024 |
| Tentative Allotment | Tue, Jul 9, 2024 |
| Initiation of Refunds | Wed, Jul 10, 2024 |
| Credit of Shares to Demat | Wed, Jul 10, 2024 |
| Tentative Listing Date | Thu, Jul 11, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on Mon, Jul 8, 2024 |
Investors can bid for a minimum of 2,000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2,000 | ₹1,36,000 |
| Retail (Max) | 1 | 2,000 | ₹1,36,000 |
| HNI (Min) | 2 | 4,000 | ₹2,72,000 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Ambey Laboratories, incorporated in 1985, manufactures agrochemical products for crop protection. The company has been serving the agrochemical sector for almost four decades.
The company manufactures and supplies 2,4-D base chemicals.
The company's manufacturing facility in Behror, Rajasthan, is certified with ISO 9001:2015 by the Quality Research Organization and ISO 14001:2015 by the United Accreditation Foundation.
The company currently produces the following products for its customer base, which includes large corporates like Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited, and SC Formulator Co. Ltd:
As of October 31, 2023 the company employs 220 people in various departments.
| Period Ended | 31 Jan 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 8,620.84 | 5,761.85 | 5,592.94 | 4,461.80 |
| Total Income | 10,043.69 | 10,743.47 | 8,511.19 | 8,241.54 |
| Profit After Tax | 607.73 | 456.93 | 357.47 | 1,033.67 |
| Net Worth | 3,431.34 | 2,363.60 | 1,906.67 | -786.39 |
| Reserves and Surplus | 1,562.46 | 588.66 | 131.73 | -1,275.74 |
| Total Borrowing | 2,005.44 | 1,365.22 | 1,804.86 | 3,292.98 |
| Amount in ₹ Lakhs | ||||
The market capitalization of Ambey Laboratories IPO is ₹171.64 Cr.
KPI as of Wed, Jan 31, 2024.
| KPI | Values |
|---|---|
| ROE | 20.80% |
| ROCE | 13.14% |
| Debt/Equity | 0.58 |
| RoNW | 20.80% |
| PAT Margin | 6.01% |
| Price to Book Value | 3.58 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS Rs | 2.44 | 2.89 |
| P/E (x) | 27.81 | 23.54 |
The company intends to utilize the Net Proceeds for the following objects:
[Dilip Davda] The company is operating in a highly competitive and fragmented segment of agrochemicals. It has posted inconsistency in its bottom lines for the reported periods. There is some garble in the offer documents on financial data. Based on FY24 annualized super earnings, the issue appears aggressively priced discounting all near term positives. There is no harm in skipping this “High Risk/Low Return” bet. Read detail review...
| Listing Date | July 11, 2024 |
| BSE Script Code | |
| NSE Symbol | AMBEY |
| ISIN | INE0M3I01029 |
| Final Issue Price | ₹68 per share |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹68.00 |
| Open | ₹85.00 |
| Low | ₹85.00 |
| High | ₹89.25 |
| Last Trade | ₹89.25 |
Ambey Laboratories Ltd.
Ground Floor, Property No.555
Tarla Mohalla,
Ghitorni
South West Delhi, New Delhi, 110030
Phone: 0124-4000788
Email: cs@ambeylab.com
Website: http://www.ambeylab.com/
MUFG Intime India Pvt.Ltd.
Phone: +91-22-4918 6270
Email: ambeylab.ipo@Linkintime.co.in
Website: https://linkintime.co.in/Initial_Offer/public-issues.html
Ambey Laboratories IPO is a SME IPO of 65,70,000 equity shares of the face value of ₹10 aggregating up to ₹44.68 Crores. The issue is priced at ₹68 per share. The minimum order quantity is 2000.
The IPO opens on July 4, 2024, and closes on July 8, 2024.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Ambey Laboratories IPO using UPI as a payment gateway. Zerodha customers can apply in Ambey Laboratories IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Ambey Laboratories IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Ambey Laboratories IPO opens on July 4, 2024 and closes on July 8, 2024.
Ambey Laboratories IPO lot size is 2000, and the minimum amount required for application is ₹1,36,000.
You can apply in Ambey Laboratories IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Ambey Laboratories IPO will be done on Tuesday, July 9, 2024, and the allotted shares will be credited to your demat account by Wednesday, July 10, 2024. Check the Ambey Laboratories IPO allotment status.
The Ambey Laboratories IPO listing date is on Thursday, July 11, 2024.
Useful Articles
RHP